Tetrabenazine (TBZ) has shown to be effective in the treatment of chorea; it acts by blocking the vesicular monoamine transporter 2 (VMAT-2) in the CNS, reducing dopamine levels. The gene discussed is SLC18A2; the disease is choreatic disease.